Reductions in glucose among postmenopausal women who use and do not use estrogen therapy

Menopause

Volumn 20, Issue 4, 2013, Pages 393-400

  Kim, Catherine ^a   Kong, Shengchun ^a   Laughlin, Gail A ^b   Golden, Sherita H ^c   Mather, Kieren J ^d   Nan, Bin ^a   Randolph, John F ^a   Edelstein, Sharon L ^e   Labrie, Fernand ^f,g   Buschur, Elizabeth ^a   Barrett Connor, Elizabeth ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d INDIANA UNIVERSITY   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f UNIVERSITÉ LAVAL   (Canada)

^g AL IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY IMSIU   (Saudi Arabia)

Author keywords

Estrogen; Glucose; Hormone therapy; Menopause; Progestogen

Indexed keywords

2 HOUR POSTCHALLENGE GLUCOSE; ESTROGEN; FASTING PLASMA GLUCOSE; GLUCOSE; METFORMIN; PLACEBO; SEX HORMONE BINDING GLOBULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILATERAL OOPHORECTOMY; BODY WEIGHT; CASE REPORT; DIET RESTRICTION; ESTROGEN THERAPY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; LOW FAT DIET; ORAL GLUCOSE TOLERANCE TEST; OVARIECTOMY; PHYSICAL ACTIVITY; POSTMENOPAUSE;

BEHAVIOR THERAPY; BLOOD GLUCOSE; DIABETES MELLITUS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FASTING; FEMALE; FOOD; GLUCOSE INTOLERANCE; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; METFORMIN; MIDDLE AGED; OVARIECTOMY; PLACEBOS; POSTMENOPAUSE; SEX HORMONE-BINDING GLOBULIN;

EID: 84876164859     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e3182703b73     Document Type: Article

References (24)

1. Kim C, Nan B, Laughlin G, et al. Endogenous sex hormone changes in postmenopausal women in the Diabetes Prevention Program. J Clin Endocrinol Metab 2012;97:2872-2880.
2. Kalyani R, Franco M, Dobs A, et al. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab 2009;94:4127-4135.
3. Oh J, Barrett-Connor E, Wedick N, Wingard D. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo Study. Diabetes Care 2002;25:55-60.
4. Ding E, Song Y, Manson J, Rifai N, Buring J, Liu S. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia 2007;50:2076-2084.
5. Knowler W, Barrett-Connor E, Fowler S, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
6. Lambrinoudaki I, Armeni E, Rizos D, et al. Sex hormones in postmenopausal women receiving low-dose hormone therapy: the effect of BMI. Obesity (Silver Spring) 2011;19:988-993.
7. Espeland M, Hogan P, Fineberg S, et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Invest Diabetes Care 1998;21:1589-1595.
8. Troisi R, Cowie C, Harris M. Hormone replacement therapy and glucose metabolism. Obstet Gynecol 2000;96:655-670.
9. Zhang Y, Howard B, Cowan L, et al. The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in American Indian postmenopausal women: the Strong Heart Study. Diabetes Care 2002;25: 500-504.
10. van Genugten R, Utzschneider K, Tong J, et al. Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes. Diabetes 2006;55:3529-3535.
11. Davidson M, Maki H, Marx P, et al. Effects on continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Arch Intern Med 2000;160:3315-3325.
12. Kanaya A, Herrington D, Vittinghoff E, et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. Ann Intern Med 2003;138:1-9.
13. Sites C, L'Hommedieu G, Toh M, Brochu M, Cooper B, Fairhurst P. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005;90: 2701-2707.
14. Godsland I, Manassiev N, Felton C, et al. Effects of low and high-dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women. Clin Endocrinol (Oxf) 2004;60: 541-549.
15. Rossouw J, Anderson G, Prentice R, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.
16. Kitabchi A, Temprosa M, Knowler W, et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetes Prevention Program: effects of lifestyle intervention and metformin. Diabetes 2005; 54:2404-2414.
17. Labrie F, Martel C, Balser J. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: the role of the ovary? Menopause 2011;18:30-43.
18. Sodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17A to human plasma proteins at body temperature. J Steroid Biochem 1982;16: 801-810.
19. Hamman R, Wing R, Edelstein S, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006;29:2102-2107.
20. Bray G, Jablonski K, Fujimoto W, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr 2008;87:1212-1218.
21. Peter A, Kantartzis K, Machann J, et al. Relationship of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes 2010;59:3167-3173.
22. Crandall J, Schade D, Ma Y, et al. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci 2006;61:1075-1081.
23. Patel S, Iqbal N, Kaul S, et al. Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial. Fertil Steril 2010;94:2161-2166.
24. Tepper P, Randolph J Jr, McConnell D, et al. Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among Women in the Study of Women's Health Across the Nation (SWAN). J Clin Endocrinol Metab 2012;doi:10.1210/jc.2012-1422.